Cardinal Health Inc. (CAH) exceeded expectations with its fiscal first-quarter profit, leading to a surge in share prices. The drug distributor reported a record-breaking climb of 1.3% in premarket trading on Friday. Although revenue fell slightly below projections, the company raised its full-year outlook.
Impressive Performance
Net income for the quarter ending September 30 dropped to $5 million, or 2 cents a share, compared to $110 million, or 40 cents a share, in the same period last year. However, after adjusting for nonrecurring items such as a $581 million goodwill impairment connected to the medical business, adjusted earnings per share rose by an impressive 44% to reach $1.73. This figure surpassed the FactSet consensus of $1.40.
Steady Revenue Growth
While revenue grew by 10.4% to $54.76 billion, it fell just short of the FactSet consensus of $54.85 billion. Pharmaceutical revenue experienced a notable increase of 11.4% to $51.0 billion, although it missed the projection of $51.3 billion. On the other hand, medical revenue remained steady at $3.8 billion as expected.
Positive Outlook
For fiscal 2024, Cardinal Health Inc. has raised its adjusted EPS guidance range from $6.50-$6.75 to $6.75-$7.00. This optimistic outlook reinforces the company's confidence in its future financial performance.
Market Reaction
While the S&P 500 has experienced a decline of 4.1% over the past three months, Cardinal Health Inc.'s stock has remained relatively stable during the same period.
Overall, Cardinal Health Inc.'s strong first-quarter profit results and improved outlook demonstrate its resilience and ability to navigate challenging market conditions effectively.
Our Latest News
Magnificent Seven Tech Stocks Hint at Dividend Surge
The Magnificent Seven tech stocks, including Meta Platforms Inc., are paving the way for a wave of dividends in the near future. Investors are eager for announc...
Severe U.S. Winter Weather Breaks Consumption Record, Natural Gas Prices Drop
Severe winter weather sets consumption record, lowers natural gas prices. Traders puzzled by decreased prices despite increased demand. Spot prices forecasted t...
Bitcoin: A Superior Form of Money
Researchers at Fidelity Investments reaffirm their belief in bitcoin as a superior form of money, citing its performance and potential as a monetary instrument....